17
Participants
Start Date
April 30, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
December 31, 2012
TPI 287
Starting dose of 160 mg/m\^2 as a 60-minute (± 10 minutes) IV infusion once every 3 weeks, (i.e., 1 cycle = 21 days).
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Cortice Biosciences, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER